“breeher, laura”的搜索结果,显示 881-890 项,共有 4054 项
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Vallow, Laura A. M.D.. Florida. 来自妙佑医疗国际员工 · 申请预约 · 关于. Feb. 28, 2025. 打印. 显示参考文献. Breast cancer treatment (PDQ) — Patient version.
The purpose of this study is to collect blood and stool samples to validate and improve the performance of stool and blood DNA markers for inflammatory ...
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握几十种专业技能,齐心协力,确保高品质治疗与成功 ...
This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...
It has been shown that patients with advanced ovarian cancer may suffer from high levels of cancer –specific distress, depression and anxiety. It has also been ...
Rochester, Minn. The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by ...
To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...
Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...
放射肿瘤科. Oluwadamilola T. Oladeru,医学博士、文科硕士 · Laura A. Vallow,医学博士. 放射科. Hillary W. Garner,医学博士 · Santo Maimone, IV,医学博士 · Robert ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。